An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.
Clinical trial NCT00228059 · COMPLETED
Trial details
- NCT number
- NCT00228059
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2007-07-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.